Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 143   

Articles published

GSK 1,671.10 -3.90 (-0.23%)
price chart
GSK, AT&T and Verizon join advertising boycott on Google over extremist content
Google's European boss Matt Brittin apologised to clients on Monday after several brands suspended advertising on the search engine and on YouTube, including Marks & Spencer (LON:MKS), the BBC, HSBC Holdings plc (LON:HSBA), Lloyds Banking ...
Major brands aren't happy they're still appearing next to online ...  Financial Post
Is a GlaxoSmithKline plc buyout back on the cards?
Merger mania is sweeping the stock market. It seems no company is safe as both domestic and international firms swoop down on venerable targets.
GlaxoSmithKline plc 12.3% Potential Upside Indicated by Berenberg
GlaxoSmithKline plc with EPIC/TICKER LON:GSK has had its stock rating noted as 'Reiterates' with the recommendation being set at 'HOLD' this morning by analysts at Berenberg.
GlaxoSmithKline plc (GSK) Rating Reiterated by Liberum Capital  Chaffey Breeze
GlaxoSmithKline plc (GSK) Receives New Coverage from Analysts at Liberum Capital  BNB Daily (blog)
Sell-side is Weighing in on GlaxoSmithKline PLC (NYSE:GSK) Earnings & Targets
Wall Street analysts have a current quarter EPS estimate of $0.59 on shares of GlaxoSmithKline PLC (NYSE:GSK). Analysts and investors will be looking ahead to the next company earnings report which is scheduled to be on or around 2017-04-26 for the ...
The GlaxoSmithKline plc (GSK) Earns “Sell” Rating from Societe Generale  Petro Global News 24
GlaxoSmithKline plc's (GSK) Sell Rating Reaffirmed at Societe Generale  The Cerbat Gem
GlaxoSmithKline plc (LSE:GSK) Dividend Growth in Focus
Shares of GlaxoSmithKline plc (LSE:GSK) currenty have a 10 year dividend growth rate of 0.07177. This number is calculated using the geometric average which provides the typical value of dividend growth over the specified period using the product of ...
Why GlaxoSmithKline plc Edged Higher in February
According to data from S&P Global Market Intelligence, shares of the British drugmaker GlaxoSmithKline (NYSE:GSK) rose by 7.36% last month. The exact reason for Glaxo's strong February, however, isn't altogether clear. After all, the market barely ...
GlaxoSmithKline plc 7.2% Potential Decrease Indicated by Barclays Capital  DirectorsTalk Interviews
Inspecting more closely technicals of GlaxoSmithKline plc (GSK)
With all other things going on, GlaxoSmithKline plc (NYSE:GSK) has been on a run - rising 11.91 percent in just three months.
GlaxoSmithKline plc 7.7% Potential Decrease Indicated by Exane BNP Paribas
GlaxoSmithKline plc with EPIC/TICKER LON:GSK has had its stock rating noted as 'Reiterates' with the recommendation being set at 'UNDERPERFORM' today by analysts at Exane BNP Paribas.
GlaxoSmithKline plc (GSK) Stock Rating Reaffirmed by BNP Paribas  Chaffey Breeze
GlaxoSmithKline PLC (LON:GSK) target price held steady at 1520.00GBX, issued ...  Breaking Finance News
In accordance with Section 203.01 of the New York Stock Exchange Listed Company Manual, GlaxoSmithKline plc ("GSK") announces that on 17 March 2017 it filed with the Securities and Exchange Commission an Annual Report on Form 20-F that included ...
GSK – GlaxoSmithKline plc: Publication of 2016 Annual Financial Report
GlaxoSmithKline plc (the 'Company') will today publish on the Company's website,, its Annual Report for the year ended 31 December 2016 (the '2016 Annual Report').